🇺🇸 FDA
Patent

US 9233121

Compositions and methods for the treatment of cancer

granted A61KA61K31/7068A61K31/713

Quick answer

US patent 9233121 (Compositions and methods for the treatment of cancer) held by BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA expires Mon Jan 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA
Grant date
Tue Jan 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K31/7068, A61K31/713